top of page

Respiratory and Allergy:
Developing new treatments faster

Leads: Prof Paul Elkington

 

We are looking into how we can develop new treatments for respiratory diseases and allergies in a much shorter time frame, with higher success rates.

Paul Elkington.tif

Health needs we are tackling

​

 

How can we develop new treatments in a much shorter time frame, with higher success rates?

 

We are developing a pipeline to accelerate the development of new treatments from new targets to proof-of-concept:

 

  • Laboratory research: we are developing advanced cellular models in the laboratory to translate ‘omics’ driven disease understanding into candidate therapies.

​​

  • Clinical trials: we are taking laboratory results and accelerating their progression into clinical trials to show proof-of-concept.

 

bottom of page